Addiction

The AMA House of Delegates recently updated a policy that seeks to increase access to evidence-based drug addiction treatment among “justice-involved individuals,” a press release said.

Concomitant targeting of smoking cessation and drinking reduction via pharmacotherapy appeared feasible, according to results of a randomized clinical trial published in American Journal of Psychiatry.

More than one-fourth of adults with CVD use tobacco products and few of them quit over 5 years, researchers reported.

A 10-item screen for alcohol use disorder appeared valuable for clinical and genetic studies related to the disorder, according to results of a genome-wide association study published in American Journal of Psychiatry.

Secondhand smoke exposure was associated with elevated odds of HF, especially in men, according to a presentation at the American College of Cardiology Scientific Session.

Stigmatization surrounding alcohol use disorder is high compared with most other mental health conditions, according to results of a systematic review published in Alcoholism: Clinical & Experimental Research.

A scalable, multicomponent intervention for smoking cessation appeared effective among people with psychiatric disorders following hospital discharge, according to results of a randomized clinical trial published in JAMA Psychiatry.

A collaborative care model that utilizes buprenorphine-waivered physicians and community pharmacists was associated with high rates of opioid use disorder treatment retention and adherence, results of a pilot study showed.

Risk drinking levels increased significantly from 2001 and 2002 to 2012 and 2013, according to an analysis of nationally representative surveys published in American Journal of Psychiatry.

Incidence of subsequent long-term benzodiazepine and related drug use following their initiation appeared high, according to results of a population-based cohort study published in JAMA Network Open.